AI Article Synopsis
- Primary care physicians play a crucial role in providing musculoskeletal (MSK) care, but there's limited information on the injection practices of family medicine residents (FMRs), especially those following a sports medicine (SM) track.
- This study analyzed data from PGY-2 and PGY-3 residents comparing the volume of MSK injections performed by SM track residents (SMRs) versus traditional FMRs (non-SMRs) from 2018-2021.
- Findings indicated that SMRs performed significantly more MSK injections per patient than non-SMRs, particularly in their third year, suggesting that participation in an SM track enhances procedural experience.
Article Abstract
Background And Objectives: Primary care physicians (PCPs) are front line providers of musculoskeletal (MSK) care and MSK injections. Little is known about the volume of common MSK injections performed by FM residents (FMRs) and those residents participating in a longitudinal clinical sports medicine (SM) track. This study outlines an SM track and demonstrates the MSK procedural experience of SM track residents (SMRs) and traditional FMRs (non-SMRs).
Methods: We utilized a retrospective study design. We compared billing codes and provider information for common MSK injections for the second (PGY-2) and third (PGY-3) postgraduate years for non-SMRs (n=39) and SMRs (n=7) graduating between 2018-2021. We used the average number of patient encounters for each comparison group (non-SMRs vs SMRs) to determine the percentage of patients receiving an MSK injection in each cohort by PGY status.
Results: Of patients receiving MSK injections across both groups, the most common was the landmark-guided large joint injection (64.23%), and the most frequent site was the knee (47.00%). SMRs performed significantly more MSK injections per patient evaluated compared to non-SMRs while in the SM clinic (PGY-2: 2.706% vs 0.913%, P<.001; PGY-3: 4.276% vs 0.862%, P<.001). No significant differences existed between PGY-2 groups when the influence of the SM clinic was removed, but PGY-3 SMRs performed significantly more injections than PGY-3 non-SMRs (1.225% vs 0.862%, P<.011).
Conclusions: An SM track in the FM residency is associated with an increased volume of MSK injections among SMRs compared to their graduate year-matched non-SMRs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.22454/FamMed.2022.626280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Activation of MSK-1 exacerbates neuropathic pain through histone H3 phosphorylation in the rats' dorsal root ganglia and spinal dorsal horn.
Brain Res Bull
December 2024
Department of Physiology and Neurobiology, School of Basic Medical Sciences, Zhengzhou University, 100 Science Avenue, Zhengzhou 450001, China. Electronic address:
The exact mechanism underlies the development of neuropathic pain is not yet completely understood. Mitogen and stress-activated kinase 1 (MSK-1) is an important downstream kinase of the mitogen-activated protein kinase (MAPK). It has been extensively studied in the central nervous system, but whether MSK-1 is associated with the neuropathic pain remains elusive.
View Article and Find Full Text PDFMinimally invasive interventional guided imaging therapies of musculoskeletal tumors.
Quant Imaging Med Surg
November 2024
Department of Radiology, MSK Unit, The Clinical Diagnostic Imaging Centre (CDIC), Hospital Clinic, Universitat de Barcelona (UB), Barcelona, Spain.
Article Synopsis
- Historically, musculoskeletal (MSK) tumors have been treated separately, but the complications from metastases, like pain and fractures, require a team of experts to decide on the best treatments, including surgery, radiation, or chemotherapy.
- * Recently, minimally invasive interventional therapies, particularly image-guided ablation techniques, have gained traction as promising options to effectively treat MSK tumors, offering less invasive alternatives.
- * Imaging methods like CT, which is preferred for its accessibility, guide these interventions, which include techniques like radiofrequency ablation and cryoablation, sometimes combined with other treatments for better tumor control.
Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.
Int J Mol Sci
October 2024
Department of Hematology and Oncology, Graduate School of Medicine, Faculty of Medicine, Osaka University, Osaka 565-0871, Japan.
The advent of recycling antibodies, leveraging pH-dependent antigen binding and optimized FcRn interaction, has advanced the field of antibody therapies, enabling extended durability and reduced dosages. Eculizumab (Soliris) demonstrated the efficacy of C5 inhibitors for paroxysmal nocturnal hemoglobinuria (PNH), while its derivative, ravulizumab (Ultomiris), recognized as a recycling antibody, extended the dosing intervals. However, limitations including intravenous administration and inefficacy in patients with the R885H single-nucleotide polymorphism (SNP) in C5 could necessitate alternative solutions.
View Article and Find Full Text PDFLong-term Immunity of a Microneedle Array Patch of SARS-CoV-2 S1 Protein Subunit Vaccine Irradiated by Gamma Rays in Mice.
bioRxiv
October 2024
Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- COVID-19 vaccines successfully reduce both symptomatic infections and severe outcomes, but unequal distribution has led to vaccine-resistant strains, especially in lower-income countries.
- The study introduces a new approach using dissolved microneedle array patches (MAP) with the S1 monomer and RS09, which enhances immune response and provides a longer-lasting immunity compared to traditional vaccination methods.
- MAP vaccines show impressive stability and efficacy even after long-term storage, with minimal degradation at high temperatures, suggesting they could be a viable alternative to existing cold-chain-dependent vaccines.
[F]TFB PET/CT misses intense [I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
EJNMMI Res
October 2024
Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, P.O. Box 77, New York, NY, 10065, USA.
Article Synopsis
- The study investigates the effectiveness of Fluorine 18-labelled tetrafluoroborate ([F]TFB) as an imaging alternative to iodine for assessing metastatic thyroid cancer and potential radioiodine treatment success.
- Five patients participated in the research, receiving both [F]TFB and iodine imaging on the same day. Results showed that [F]TFB identified 58% of lesions compared to 91% for iodine imaging, indicating its lower sensitivity.
- The conclusion drawn highlights that [F]TFB did not successfully predict iodine uptake in patients undergoing redifferentiation therapy, raising questions about its reliability for other treatment cases or in untreated patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!